Compile Data Set for Download or QSAR
Report error Found 186 of ic50 data for polymerid = 338,50001479
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683329(US20240217922, Example 6 | US20240217922, Example ...)
Affinity DataIC50: 60nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683329(US20240217922, Example 6 | US20240217922, Example ...)
Affinity DataIC50: 60nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM669885(US20240132514, Example 2 | 2-({5H,6H,8H-pyrano[3,4...)
Affinity DataIC50: 60nMAssay Description:The compound affinity was determined by measuring the inhibition of 3H-neurotensin and/or 125I-neurotensin binding to human full length sortilin usin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159226(US9682967, 44 | US10195186, Example 46)
Affinity DataIC50: 88nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445041(CHEMBL3098768 | US9682967, 46 | US10195186, Exampl...)
Affinity DataKi:  84nM IC50: 88nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683325(US20240217922, Example 1 | US20240217922, Example ...)
Affinity DataIC50: 90nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683341(US20240217922, Example 18)
Affinity DataIC50: 90nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445041(CHEMBL3098768 | US9682967, 46 | US10195186, Exampl...)
Affinity DataIC50: 100nMAssay Description:Displacement of [3H]-neurotensin from sortilin (unknown origin) incubated 30 mins prior to [3H]-neurotensin addition measured after 6 hrs by scintill...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683340(US20240217922, Example 17)
Affinity DataIC50: 100nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM669885(US20240132514, Example 2 | 2-({5H,6H,8H-pyrano[3,4...)
Affinity DataIC50: 105nMAssay Description:The compound affinity was determined by measuring the inhibition of 3H-neurotensin and/or 125I-neurotensin binding to human full length sortilin usin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683335(US20240217922, Example 13)
Affinity DataIC50: 120nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683327(US20240217922, Example 4)
Affinity DataIC50: 140nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683334(US20240217922, Example 12)
Affinity DataIC50: 150nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445042(CHEMBL3098767 | US9682967, 7 | US10195186, Example...)
Affinity DataIC50: 170nMAssay Description:Displacement of [3H]-neurotensin from sortilin (unknown origin) incubated 30 mins prior to [3H]-neurotensin addition measured after 6 hrs by scintill...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445042(CHEMBL3098767 | US9682967, 7 | US10195186, Example...)
Affinity DataIC50: 170nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445042(CHEMBL3098767 | US9682967, 7 | US10195186, Example...)
Affinity DataKi:  162nM IC50: 170nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445055(CHEMBL3098744 | US9682967, 43 | US10195186, Exampl...)
Affinity DataIC50: 200nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159232(US9682967, 45 | US10195186, Example 47)
Affinity DataKi:  190nM IC50: 200nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Mouse)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 220nMAssay Description:The Sortilin assay was performed in total volume of 40 μl in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Mouse)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataKi:  210nM IC50: 220nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In DepthDetails
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50248034(CHEMBL506981 | SR 48692 | 2-{[1-(7-Chloro-quinolin...)
Affinity DataIC50: 238nMAssay Description:Binding affinity to NTR3 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159140(US9682967, 18 | US10195186, Example 18)
Affinity DataIC50: 240nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683337(US20240217922, Example 14)
Affinity DataIC50: 240nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159140(US9682967, 18 | US10195186, Example 18)
Affinity DataKi:  229nM IC50: 240nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 260nMAssay Description:The pro Sortilin assay was performed in total volume of 20 μl in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA ...More data for this Ligand-Target Pair
In DepthDetails
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683328(US20240217922, Example 5)
Affinity DataIC50: 270nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683339(US20240217922, Example 16)
Affinity DataIC50: 290nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159213(US9682967, 42 | US10195186, Example 44)
Affinity DataIC50: 300nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159226(US9682967, 44 | US10195186, Example 46)
Affinity DataKi:  286nM IC50: 300nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683338(US20240217922, Example 15)
Affinity DataIC50: 310nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 316nMAssay Description:Displacement of [3H]-neurotensin from human His6-tagged sortilin pretreated for 30 mins followed by [3H]-neurotensin addition after 6 hrs measured fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 330nMAssay Description:Displacement of [3H]-neurotensin from sortilin (unknown origin) incubated 30 mins prior to [3H]-neurotensin addition measured after 6 hrs by scintill...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM669886(US20240132514, Example 3 | 2-{[6- (hydroxymethyl)p...)
Affinity DataIC50: 340nMAssay Description:The compound affinity was determined by measuring the inhibition of 3H-neurotensin and/or 125I-neurotensin binding to human full length sortilin usin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50130880(pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-L...)
Affinity DataIC50: 360nMAssay Description:Displacement of [3H]-neurotensin from human sortilin incubated 30 mins prior to [3H]-neurotensin addition measured after 6 hrs by scintillation proxi...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159138(US9682967, 16 | US10195186, Example 16)
Affinity DataIC50: 360nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159139(US9682967, 17 | US10195186, Example 17)
Affinity DataIC50: 360nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159138(US9682967, 16 | US10195186, Example 16)
Affinity DataKi:  343nM IC50: 360nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159139(US9682967, 17 | US10195186, Example 17)
Affinity DataKi:  343nM IC50: 360nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50545414(CHEMBL1852155)
Affinity DataIC50: 380nMAssay Description:Inhibition of GFP-tagged Sortilin (unknown origin) expressed in HEK293T cells after 42 hrs by FACS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50133194(Compound KK2 | CHEMBL133849)
Affinity DataIC50: 400nMAssay Description:Evaluated for binding affinity by inhibiting binding of [125I]Tyr(3)-NT to human Neurotensin receptor 3More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50133192(Compound NT | CHEMBL439494)
Affinity DataIC50: 440nMAssay Description:Evaluated for binding affinity by inhibiting binding of [125I]Tyr(3)-NT to human Neurotensin receptor 3More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 450nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In DepthDetails
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataKi:  429nM IC50: 450nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In DepthDetails
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50133188(Compound KK17 | CHEMBL336836)
Affinity DataIC50: 480nMAssay Description:Evaluated for binding affinity by inhibiting binding of [125I]Tyr(3)-NT to human Neurotensin receptor 3More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50133207(Compound KK11 | CHEMBL133378)
Affinity DataIC50: 480nMAssay Description:Evaluated for binding affinity by inhibiting binding of [125I]Tyr(3)-NT to human Neurotensin receptor 3More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159123(US9682967, 11 | US10195186, Example 11)
Affinity DataIC50: 480nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159129(US9682967, 13 | US10195186, Example 13)
Affinity DataIC50: 480nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159123(US9682967, 11 | US10195186, Example 11)
Affinity DataKi:  457nM IC50: 480nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM159129(US9682967, 13 | US10195186, Example 13)
Affinity DataKi:  457nM IC50: 480nMpH: 7.4Assay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM50445044(CHEMBL3098765 | US9682967, 34 | US10195186, Exampl...)
Affinity DataIC50: 490nMAssay Description:Displacement of [3H]-neurotensin from sortilin (unknown origin) incubated 30 mins prior to [3H]-neurotensin addition measured after 6 hrs by scintill...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 186 total ) | Next | Last >>
Jump to: